Shubha has helped streamline and implement a large target capture based NGS panel for clinical trials and translational studies. New assays have been developed to test ctDNA from cancer patients including shallow WGS. For Haematological malignancies, a custom Lymphoma panel is currently under validation which will be implemented in an upcoming trial. Her main interests are in targeted therapy of cancer, early cancer diagnostics and to interpret clinical significance of data obtained by NGS.
